Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Heatwurx Inc. (PCSA) vs Xenetic Biosciences, Inc. (XBIO)

Heatwurx Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Xenetic Biosciences, Inc. is the larger, with a market value of $5.8M against $5.2M — 1.1× the size. Xenetic Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.8×. Xenetic Biosciences, Inc. grew revenue faster over the last twelve months: 33.3% against −34.5%. Heatwurx Inc. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Xenetic Biosciences, Inc. leads on 8 and Heatwurx Inc. on 6.

Valuation

Metric PCSA XBIO Biotechnology median
P/E 1.75 n/m 7.88
P/S 38.64 1.67 11.47
P/B n/m 0.90 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.39 0.74
EV/Sales 38.45 (0.31) 10.73
Earnings yield 57.14% (48.95%) (28.84%)
Free cash flow yield (259.68%) (42.50%) (23.03%)

Profitability

Metric PCSA XBIO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (464.19%) (47.05%) (57.72%)
Return on assets (262.17%) (40.17%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PCSA XBIO Biotechnology median
Revenue growth (TTM) (34.50%) 33.30% 5.64%
EPS growth (last fiscal year) 89.29% 38.52% —
Revenue growth, 5-year CAGR — 46.78% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCSA XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.87 7.43 4.73
Net debt to EBITDA 0.40 2.78 0.96

Dividend

Metric PCSA XBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PCSA XBIO Biotechnology median
Market cap 5.17m 5.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack